Catalyst Wire Dossier Catalyst Wire Dossier

Opti-K

· VIS, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Opti-K, covering 2019-05-09 to 2024-11-22. Get the full timeline:

Most recent: Clinical Trial Update: VIS Opti-K Vision Improvement for Presbyopes

See pricing